<--- Back to Details
First PageDocument Content
Technology / Premarket approval / Medical device / Federal Food /  Drug /  and Cosmetic Act / Substantial equivalence / Investigational Device Exemption / Center for Devices and Radiological Health / Medicine / Food and Drug Administration / Health
Date: 2014-08-06 11:14:50
Technology
Premarket approval
Medical device
Federal Food
Drug
and Cosmetic Act
Substantial equivalence
Investigational Device Exemption
Center for Devices and Radiological Health
Medicine
Food and Drug Administration
Health

Portfolio Media. Inc. | 860 Broadway, 6th Floor | New York, NY 10003 | www.law360.com Phone: +[removed] | Fax: +[removed] | [removed] Medical Device Equivalence Analysis Examines 2 Factors Law3

Add to Reading List

Source URL: www.faegrebd.com

Download Document from Source Website

File Size: 364,72 KB

Share Document on Facebook

Similar Documents

Jeffrey Shuren, M.D., J.D. Director Center for Devices and Radiological Health Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MD

Jeffrey Shuren, M.D., J.D. Director Center for Devices and Radiological Health Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MD

DocID: 1tLOR - View Document

Digital Health Innovation Action Plan  Introduction FDA’s Center for Devices and Radiological Health (CDRH) puts patients at the forefront of our vision—we are driven by timely patient access to high-quality, s

Digital Health Innovation Action Plan  Introduction FDA’s Center for Devices and Radiological Health (CDRH) puts patients at the forefront of our vision—we are driven by timely patient access to high-quality, s

DocID: 1ttzz - View Document

Post-doctoral fellow position #2 – Research Focus Nanotechnology/nanotoxicology - Safety of engineered nanomaterials The Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryl

Post-doctoral fellow position #2 – Research Focus Nanotechnology/nanotoxicology - Safety of engineered nanomaterials The Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryl

DocID: 1sM2j - View Document

Sunlamps: Regulatory Issues W. Howard Cyr, Ph.D. Office of Science and Technology, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD USA  For distribution at the following meetings:

Sunlamps: Regulatory Issues W. Howard Cyr, Ph.D. Office of Science and Technology, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD USA For distribution at the following meetings:

DocID: 1srEV - View Document

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document